Cardiology - Case Reports Open access

Eosinophilic myocarditis in platelet-derived growth factor receptor α-rearranged myeloid neoplasm with central nervous system involvement: a case report

Authors

  • Maria Cristina Aloini – articles in this journal Corresponding author Email Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome; Research Unit of Cardiovascular Science, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Andrea Segreti – articles in this journal Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome; Research Unit of Cardiovascular Science, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Rosetta Melfi – articles in this journal Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome; Research Unit of Cardiovascular Science, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Francesco Grigioni – articles in this journal Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome; Research Unit of Cardiovascular Science, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
Published
27 October 2026
Issue
Early Access
Section
Cardiology - Case Reports

Abstract

Eosinophilic myocarditis is a rare inflammatory condition caused by eosinophilic infiltration of the myocardium, often associated with systemic or hematologic disorders.

We report a 31-year-old man with a newly diagnosed platelet-derived growth factor receptor α-rearranged myeloid neoplasm who presented with acute chest pain and elevated cardiac biomarkers. Echocardiography showed Loeffler-type apical involvement, coronary computed tomography angiography excluded obstructive coronary disease, and cardiac magnetic resonance (CMR) demonstrated acute non-ischemic inflammatory myocardial injury. During hospitalization, neurological symptoms revealed central nervous system involvement by the underlying myeloid neoplasm. Corticosteroids and targeted hematologic treatment resulted in marked clinical and radiologic improvement.

On long-term follow-up, CMR showed normal cardiac function with complete resolution of the inflammatory myocardial abnormalities and no residual fibrosis.

This case highlights the value of early multimodality cardiac imaging, etiologic diagnosis, and coordinated cardio-hematologic management in recognizing potentially reversible eosinophilic myocardial injury and limiting progression to irreversible cardiac sequelae.

References

  1. Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J 2025;46:3952-4041. DOI: https://doi.org/10.1093/eurheartj/ehaf192
  2. Brambatti M, Matassini MV, Adler ED, et al. Eosinophilic myocarditis. J Am Coll Cardiol 2017;70:2363-75. DOI: https://doi.org/10.1016/j.jacc.2017.09.023
  3. Shomali W, Gotlib J. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol 2024;99:946-68. DOI: https://doi.org/10.1002/ajh.27287
  4. Venkataramany BS, Brar A, Ahart Z, et al. Eosinophilic myocarditis associated with chronic eosinophilic leukemia. JACC Case Rep 2025;30:104805. DOI: https://doi.org/10.1016/j.jaccas.2025.104805
  5. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391-405. DOI: https://doi.org/10.1182/blood-2016-03-643544
  6. Legrand F, Renneville A, MacIntyre E, et al. The spectrum of FIP1L1-PDGFRA-associated chronic eosinophilic leukemia: new insights based on a survey of 44 cases. Medicine 2013;92:e1-9. DOI: https://doi.org/10.1097/MD.0b013e3182a71eba
  7. Piccirillo F, Mastroberardino S, Nafisio V, et al. Eosinophilic myocarditis: from bench to bedside. Biomedicines 2024;12:656. DOI: https://doi.org/10.3390/biomedicines12030656
  8. Kawano S, Kato J, Kawano N, et al. Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med 2011;50:975-81. DOI: https://doi.org/10.2169/internalmedicine.50.4079
  9. Aggarwal HK, Jain D, Kaverappa V, et al. Idiopathic hypereosinophilic syndrome presenting as severe Loeffler’s endocarditis. Arq Bras Cardiol 2013;100:e43-6. DOI: https://doi.org/10.5935/abc.20130081
  10. Porkka K, Koskenvesa P, Lundán T, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia. Blood 2008;112:1005-12. DOI: https://doi.org/10.1182/blood-2008-02-140665

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.